TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung Cancer.
Bessede A, Peyraud F, Besse B, Cousin S, Cabart M, Chomy F, Rey C, Lara O, Odin O, Nafia I, et al. Clin Cancer Res. 2024 Feb 16; 30(4):779-785.